DELMAR PHARMACEUTICALS, INC. FORM SC 13G

Company

TuHURA Biosciences, Inc./NV

Filed

February 13, 2013

Accession Number

0001013762-13-000230

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →